These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 14696795)

  • 1. Molecular analysis of neurofibromatosis type 1 in Turkish families using polymorphic markers.
    Oğuzkan S; Cinbiş M; Ayter S; Anlar B; Aysun S
    Turk J Pediatr; 2003; 45(3):192-7. PubMed ID: 14696795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling.
    Terzi YK; Oguzkan-Balci S; Anlar B; Aysun S; Guran S; Ayter S
    Genet Couns; 2009; 20(2):195-202. PubMed ID: 19650418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool.
    Elyakim S; Lerer I; Zlotogora J; Sagi M; Gelman-Kohan Z; Merin S; Abeliovich D
    Am J Med Genet; 1994 Dec; 53(4):325-34. PubMed ID: 7864041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the presence of the second allele of the neurofibromatosis type 1 gene in melanocytes derived from café au laitmacules of NF1 patients.
    Eisenbarth I; Assum G; Kaufmann D; Krone W
    Biochem Biophys Res Commun; 1997 Aug; 237(1):138-41. PubMed ID: 9266845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
    Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
    Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis: novel and recurrent mutations in Turkish patients.
    Terzi YK; Oguzkan S; Anlar B; Aysun S; Ayter S
    Pediatr Neurol; 2007 Dec; 37(6):421-5. PubMed ID: 18021924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.
    Colman SD; Williams CA; Wallace MR
    Nat Genet; 1995 Sep; 11(1):90-2. PubMed ID: 7550323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A de novo Alu insertion results in neurofibromatosis type 1.
    Wallace MR; Andersen LB; Saulino AM; Gregory PE; Glover TW; Collins FS
    Nature; 1991 Oct; 353(6347):864-6. PubMed ID: 1719426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetics of type 1 neurofibromatosis].
    Garavelli L; Donadio A; Sigorini M; Grassi L; Banchini G
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):89-95. PubMed ID: 11424621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis].
    Crişan M; Talu S; Florea M; Coprean D; Cosgarea R; Crişan D
    Oftalmologia; 2008; 52(4):56-61. PubMed ID: 19354164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of genetic polymorphism in neurofibromatosis type 1.
    Clementi M; Boni S; Mammi I; Favarato M; Tenconi R
    Ann Genet; 1996; 39(2):92-6. PubMed ID: 8766140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1.
    Altarescu G; Brooks B; Kaplan Y; Eldar-Geva T; Margalioth EJ; Levy-Lahad E; Renbaum P
    Hum Reprod; 2006 Aug; 21(8):2047-51. PubMed ID: 16740526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant multiple café-au-lait spots and neurofibromatosis-1: evidence of non-linkage.
    Charrow J; Listernick R; Ward K
    Am J Med Genet; 1993 Mar; 45(5):606-8. PubMed ID: 8456833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions.
    Lopez Correa C; Brems H; Lázaro C; Estivill X; Clementi M; Mason S; Rutkowski JL; Marynen P; Legius E
    Hum Mutat; 1999; 14(5):387-93. PubMed ID: 10533064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.